Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 12/20 | 0.56 |
| ▸ | NPC1 | O15118 | 11/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 9/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.56 |
| ▸ | PKM | P14618 | 4/20 | 0.56 |
| ▸ | TP53 | P04637 | 3/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.56 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 7/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.47 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.47 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.47 |
| ▸ | KDR | P35968 | 2/20 | 0.47 |
| ▸ | PKN1 | Q16512 | 1/20 | 0.46 |
| ▸ | PKN2 | Q16513 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL172216 | 0.74 | NPC1 (1.00) | RAB9ANPC1ALDH1A1KDM4ESMN1; SMN2 | |
| SCHEMBL30634854 | 0.74 | NPC1 (1.00) | RAB9ANPC1ALDH1A1KDM4ESMN1; SMN2 | |
| SCHEMBL30561047 | 0.74 | NPC1 (1.00) | RAB9ANPC1ALDH1A1KDM4ESMN1; SMN2 | |
| SCHEMBL703704 | 0.73 | NISCH (0.47) | ALDH1A1KDM4ESMN1; SMN2MAPTLMNA | |
| SCHEMBL4016240 | 0.73 | NPC1 (0.50) | RAB9ANPC1ALDH1A1KDM4ESMN1; SMN2 | |
| SCHEMBL5320905 | 0.73 | NPC1 (0.50) | RAB9ANPC1ALDH1A1KDM4ESMN1; SMN2 | |
| Water SCHEMBL9817804 | 0.72 | NPC1 (0.95) | RAB9ANPC1ALDH1A1KDM4ESMN1; SMN2 | |
| SCHEMBL239122 | 0.72 | CYP2A6 (0.37) | ALDH1A1HSD17B10HPGDTSHRTDP1 | |
| SCHEMBL467532 | 0.71 | NPC1 (0.62) | RAB9ANPC1ALDH1A1KDM4ESMN1; SMN2 | |
| SCHEMBL2991589 | 0.71 | NPC1 (0.56) | RAB9ANPC1ALDH1A1KDM4ESMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6723730-B2 | DIARYL PIPERAZINES AND RELATED COMPOUNDS USEFUL IN THE TREATMENT OF A CHRONIC AND ACUTE PAIN CONDITIONS, ITCH AND URINARY INCONTINENCE. | NEUROGEN CORPORATION | 2004-04-20 | — | — | US | claimed |
| WO-2008057300-A9 | TRPVI ANTAGONISTS AND USES THEREOF | REDPOINT BIO CORP (US) | 2008-07-24 | — | — | WO | disclosed |
| US-20080153845-A1 | TRPV1 ANTAGONISTS AND USES THEREOF | REDPOINT BIO CORPORATION (US) | 2008-06-26 | — | — | US | disclosed |
| WO-2008057300-A2 | TRPVI ANTAGONISTS AND USES THEREOF | REDPOINT BIO CORPORATION (US) | 2008-05-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080153845-A1 | TRPV1 ANTAGONISTS AND USES THEREOF | TRPV1, TRPA1, TRPV5 | RAB9A 1904/4885NPC1 623/4885ALDH1A1 2820/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.